These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10875748)

  • 1. Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.
    Kinoshita K; Watanabe Y; Asai H; Matsuoka Y
    Jpn J Pharmacol; 2000 Apr; 82(4):295-300. PubMed ID: 10875748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
    Kinoshita K; Watanabe Y; Asai H; Yamamura M; Matsuoka Y
    Br J Pharmacol; 1995 Dec; 116(8):3274-8. PubMed ID: 8719807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
    Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thyrotrophin-releasing hormone tartrate and its sustained release formulation on cerebral glucose metabolism in aged rats.
    Nakayama T; Nagai Y
    J Pharm Pharmacol; 1997 Sep; 49(9):884-91. PubMed ID: 9306256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method.
    Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
    Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
    Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
    Yamamura M; Suzuki M; Matsumoto K
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat.
    Ori C; Dam M; Pizzolato G; Battistin L; Giron G
    Anesthesiology; 1986 Aug; 65(2):152-6. PubMed ID: 3740504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone and its receptor in the cerebellum of inferior olive destroyed rat brain.
    Adachi K; Rhue BN; Li M; Izumi M; Osano H; Mitsuma T
    Neurol Res; 2000 Jun; 22(4):401-3. PubMed ID: 10874690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A TRH analog (DN-1417). Antagonistic effects on reserpine-induced decreases in local cerebral glucose utilization and cerebral monoamine levels].
    Nagai Y; Narumi S; Saji Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):315-26. PubMed ID: 3928465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T; Nagai Y
    Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
    J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.
    Kinoshita K; Yamamura M; Sugihara J
    Biol Pharm Bull; 1997 Jan; 20(1):86-7. PubMed ID: 9013814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
    Asai H; Kinoshita K; Yamamura M; Matsuoka Y
    Jpn J Pharmacol; 1999 Mar; 79(3):313-7. PubMed ID: 10230859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methiothepin reduces glucose utilization in forebrain regions of awake rats.
    Ricchieri GL; Soncrant TT; Holloway HW; Rapoport SI
    Psychopharmacology (Berl); 1987; 93(4):449-56. PubMed ID: 3124178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
    Katsumata T; Katayama Y; Ootori T; Muramatsu H; Nishiyama Y; Nakamura H; Seta T; Terashi A
    Brain Res; 2001 May; 901(1-2):62-70. PubMed ID: 11368951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
    Mailman RB; Frye GD; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.
    Boghosian JD; Luethy A; Cotten JF
    J Pharmacol Exp Ther; 2018 Jul; 366(1):105-112. PubMed ID: 29674333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.